TCF7L2长链非编码RNA:糖皮质激素信号介导双相障碍与体重指数的遗传关联
本研究利用人诱导多能干细胞来源的星形胶质细胞,发现双相障碍与体重指数GWAS风险SNP与糖皮质激素依赖的TCF7L2长链非编码RNA表达抑制相关。敲低该lncRNA可降低TCF7L2表达并改变胰岛素信号相关基因,且TCF7L2直接调控一系列双相障碍风险基因。
要点
- BD-BMI GWAS风险SNP通过糖皮质激素依赖方式抑制lncRNA-TCF7L2表达。
- lncRNA-TCF7L2在中枢神经系统高表达,在外周代谢组织如肝和胰腺不表达。
- TCF7L2直接调控双相障碍风险基因,支持中枢机制介导BD-BMI遗传风险。
核心结论
- 研究支持存在基于中枢神经系统的机制介导双相障碍与体重指数的遗传风险,该机制依赖糖皮质激素依赖的表达数量性状位点调控新型TCF7L2非编码转录本。
研究设计与样本
- 研究使用人诱导多能干细胞来源的星形胶质细胞,结合RNA测序和染色质免疫沉淀测序(ChIP-seq)数据进行分析。
主要发现
- BD-BMI GWAS风险SNP与糖皮质激素依赖的TCF7L2转录变体表达抑制相关,该变体为长链非编码RNA(lncRNA-TCF7L2)。
- lncRNA-TCF7L2在中枢神经系统高表达,但在肝脏和胰腺等外周代谢组织不表达。
- 在星形胶质细胞中敲低lncRNA-TCF7L2导致亲本基因TCF7L2表达下降,并改变一系列参与胰岛素信号和糖尿病的基因表达。
- 整合RNA测序与ChIP-seq数据显示TCF7L2直接调控一系列双相障碍风险基因。
临床怎么用
- 提示临床关注双相障碍与肥胖共病的中枢遗传机制,TCF7L2可能作为连接糖皮质激素信号、胰岛素信号与双相障碍风险的潜在靶点。
局限性
- 研究基于人诱导多能干细胞来源的星形胶质细胞体外模型,尚未在临床样本或体内验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Bipolar disorder (BD) and obesity are highly comorbid. We previously performed a genome-wide association study (GWAS) for BD risk accounting for the effect of body mass index (BMI), which identified a genome-wide significant single-nucleotide polymorphism (SNP) in the gene encoding the transcription factor 7 like 2 (TCF7L2). However, the molecular function of TCF7L2 in the central nervous system (CNS) and its possible role in the BD and BMI interaction remained unclear. In the present study, we demonstrated by studying human induced pluripotent stem cell (hiPSC)-derived astrocytes, cells that highly express TCF7L2 in the CNS, that the BD-BMI GWAS risk SNP is associated with glucocorticoid-dependent repression of the expression of a previously uncharacterized TCF7L2 transcript variant. That transcript is a long non-coding RNA (lncRNA-TCF7L2) that is highly expressed in the CNS but not in peripheral tissues such as the liver and pancreas that are involved in metabolism. In astrocytes, knockdown of the lncRNA-TCF7L2 resulted in decreased expression of the parent gene, TCF7L2, as well as alterations in the expression of a series of genes involved in insulin signaling and diabetes. We also studied the function of TCF7L2 in hiPSC-derived astrocytes by integrating RNA sequencing data after TCF7L2 knockdown with TCF7L2 chromatin-immunoprecipitation sequencing (ChIP-seq) data. Those studies showed that TCF7L2 directly regulated a series of BD risk genes. In summary, these results support the existence of a CNS-based mechanism underlying BD-BMI genetic risk, a mechanism based on a glucocorticoid-dependent expression quantitative trait locus that regulates the expression of a novel TCF7L2 non-coding transcript.
引用
- Liu D, Nguyen TTL, Gao H, et al. TCF7L2 lncRNA: a link between bipolar disorder and body mass index through glucocorticoid signaling. Mol Psychiatry. 2021. PMID: 34535768. doi:10.1038/s41380-021-01274-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。